FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Careen Tang

Research Profile

Chemicals & Drugs

Disorders

Phenomena

Phosphorylation

Anatomy

Living Beings

Procedures

Flow Cytometry

Physiology

Co-author Network

Publications

TOP 3
Haizhong Feng; Tim Fenton; Frank B Furnari; Ronald L Hamilton; Bo Hu; Michael J Jarzynka; Terrance G Johns; Susan Keezer; Y Li; Ryo Nishikawa; Jann N. Sarkaria; Careen K Tang; Kristiina Vuori; Webster K Cavenee; Tao Cheng; Shi-Yuan Cheng
Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis.
Hua Su; Elias J Sobrino Najul; Theodore A Toth; Crystal Mei Ng; Sophie A Lelievre; Matthew Fred; Careen K Tang
Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis.
Massod Rahimi; Theodore A Toth; Careen K Tang
CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Careen Tang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Haizhong Feng; Tim Fenton; Frank B Furnari; Ronald L Hamilton; Bo Hu; Michael J Jarzynka; Terrance G Johns; Susan Keezer; Y Li; Ryo Nishikawa; Jann N. Sarkaria; Careen K Tang; Kristiina Vuori; Webster K Cavenee; Tao Cheng; Shi-Yuan Cheng
Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):3018-23.
2011: Hua Su; Elias J Sobrino Najul; Theodore A Toth; Crystal Mei Ng; Sophie A Lelievre; Matthew Fred; Careen K Tang
Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis.
Cancer letters 2011;307(2):132-40.
2011: Massod Rahimi; Theodore A Toth; Careen K Tang
CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.
Cancer letters 2011;306(1):43-51.
2010: Massod Rahimi; Kai-Ling Huang; Careen K Tang
3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.
Cancer letters 2010;295(1):59-68.
2010: Takayuki Otani; Toshihiro Hashizume; Tadahiro Nagaoka; Tomoko Fukuda; Careen K Tang; David S Salomon; Masaharu Seno
Production of biologically active IgG hinge-tag soluble epidermal growth factor receptors (ErbB).
Biotechnology letters 2010;32(3):361-6.
2009: Sean O'Malley; Hua Su; Tao Zhang; Crystal Ng; Hong Ge; Careen K Tang
TOB suppresses breast cancer tumorigenesis.
International journal of cancer. Journal international du cancer 2009;125(8):1805-13.
2008: Hong Yu; Xiaoqi Gong; Xunyi Luo; Wei Han; Ge Hong; Baljit Singh; Careen K Tang
Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways.
Cancer biology & therapy 2008;7(11):1818-28.
2006: Yves A De Clerck; Bernard E Weissman; Dihua Yu; Ramon Parsons; Menashe Bar-Eli; Pradip Roy-Burman; Victoria L Seewaldt; Anne E Cress; Lucia R Languino; Surinder Batra; Careen K Tang; Shijie Sheng; Wen-Tien Chen; Srikumar Chellappan; Shi-Yuan Cheng; Stephan Ladisch; James B McCarthy; Lisa M Coussens; Michael B Cohen
Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.
Cancer biology & therapy 2006;5(12):1588-99.
2006: Wei Han; Tao Zhang; Hong Yu; John G Foulke; Careen K Tang
Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII.
Cancer biology & therapy 2006;5(10):1361-8.
2003: Xunyi Luo; Xiaoqi Gong; Careen K Tang
Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme.
International journal of cancer. Journal international du cancer 2003;104(6):716-21.
2003: Miaw-Sheue Tsai; Lisa A Shamon-Taylor; Inderjit Mehmi; Careen K Tang; Ruth Lupu
Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
Oncogene 2003;22(5):761-8.
2002: Hong Ge; Xiaoqi Gong; Careen K Tang
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.
International journal of cancer. Journal international du cancer 2002;98(3):357-61.
2000: Careen K Tang; X Q Gong; Moscatello David; Albert J Wong; Marc Lippman
Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Cancer research 2000;60(11):3081-7.
1999: Careen K Tang; X Z Concepcion; M Milan; Xiaoqi Gong; Elizabeth Montgomery; Marc Lippman
Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.
Cancer research 1999;59(20):5315-22.
1999: Caterina Bianco; S Kannan; ML De Santis; Masaharu Seno; Careen K Tang; I Martinez-Lacaci; Norma Kim; Brenda Wallace-Jones; Marc Lippman; Andreas Ebert; Christian Wechselberger; David S Salomon
Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor.
The Journal of biological chemistry 1999;274(13):8624-9.
1998: Careen K Tang; D J Goldstein; J Payne; Frank Czubayko; M Alimandi; Ling Mei Wang; JH Pierce; Marc Lippman
ErbB-4 ribozymes abolish neuregulin-induced mitogenesis.
Cancer research 1998;58(15):3415-22.
1996: Careen K Tang; C Perez; Thomas W Grunt; C Waibel; C Cho; R Lupu
Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.
Cancer research 1996;56(14):3350-8.